The frequency of aCL was predominantly higher (60.0%) in our study compared to the studies conducted in Singapore [9], Brazil [26], Israel [25], Spain [21], and Italy [20,22], whereas aCL antibody was detected in 1.0–21.8% of the cancer patients. The gene discussed is ACLY; the disease is cancer.